Skip to Content

← See all Motion Sickness Relief brands

Motion Sickness Relief by SUPERVALU INC.

Dosage form: tablet
Ingredients: MECLIZINE HYDROCHLORIDE 25mg
Labeler: SUPERVALU INC.
NDC Code: 41163-304

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Equaline 44-403

Active ingredient (in each tablet)

Meclizine HCl 25 mg

Purpose

Antiemetic

Uses

for the prevention and treatment of nausea, vomiting, or dizziness associated with motion sickness 

Warnings

Do not use

for children under 12 years of age unless directed by a doctor.

Ask a doctor before use if you have
  • glaucoma
  • difficulty in urination due to an enlargement of the prostate gland
  • a breathing problem such as emphysema or chronic bronchitis

Ask a doctor or pharmacist before use if you are

 taking sedatives or tranquilizers.

When using this product
  • drowsiness may occur
  • avoid alcoholic drinks
  • alcohol, sedatives, and tranquilizers may increase drowsiness
  • use caution when driving a motor vehicle or operating machinery 

If pregnant or breast-feeding,

 ask a health professional before use.

Keep out of reach of children.

 In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions
  • to prevent motion sickness, take the first dose one hour before starting activity
  • to prevent or treat motion sickness: 1 to 2 tablets once daily for adults and children 12 years and over, or as directed by a doctor

Other information
  • store at 25ºC (77ºF); excursions permitted between 15º-30ºC (59º-86ºF)
  • protect from heat and humidity
  • use by expiration date on package

Inactive ingredients

corn starch, D&C yellow #10 aluminum lake, lactose, magnesium stearate, silica gel

Questions of comments?

1-877-932-7948

Principal Display Panel

EQUALINE®

compare to Dramamine®
Less Drowsy Formula

active ingredient*

NDC 41163-304-02

motion sickness relief
meclizine HCl tablets 25 mg
(antiemetic)

less drowsy formula

helps prevent nausea & dizziness
due to motion sickness
for up to 24 hours

12 tablets 

TAMPER EVIDENT:
USE ONLY IF THIS BLISTER IS INTACT

actual size

DOES NOT CONTAIN GLUTEN

*This product is not manufactured or distributed by
Prestige Brands, Inc., owner of the registered trademark
Dramamine® Less Drowsy Formula.
50844        REV0715B40302

DISTRIBUTED BY SUPERVALU INC.
EDEN PRAIRIE, MN 55344 USA
Contact us at 1-877-932-7948

SUPERVALU QUALITY
Guaranteed

We’re committed to your
satisfaction and guarantee
the quality of this product.
Contact us at 1-877-932-7948, or
www.supervalu-ourownbrands.com.
Please have package available.

Equaline 44-403

MOTION SICKNESS RELIEF 
meclizine hcl tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:41163-304
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
MECLIZINE HYDROCHLORIDE (MECLIZINE) MECLIZINE HYDROCHLORIDE25 mg
Inactive Ingredients
Ingredient NameStrength
D&C YELLOW NO. 10 
MAGNESIUM STEARATE 
STARCH, CORN 
LACTOSE 
SILICON DIOXIDE 
Product Characteristics
ColorYELLOWScoreno score
ShapeROUNDSize9mm
FlavorImprint Code44;403
Contains    
Packaging
#Item CodePackage Description
1NDC:41163-304-021 BOTTLE, PLASTIC in 1 PACKAGE
112 TABLET in 1 BOTTLE, PLASTIC
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC MONOGRAPH FINALpart33606/24/2002
Labeler - SUPERVALU INC. (006961411)
Establishment
NameAddressID/FEIOperations
LNK International, Inc.038154464PACK(41163-304)
Establishment
NameAddressID/FEIOperations
LNK International, Inc.832867894MANUFACTURE(41163-304)
Establishment
NameAddressID/FEIOperations
LNK International, Inc.832867837PACK(41163-304)

 
SUPERVALU INC.

← See all Motion Sickness Relief brands

Medically reviewed on Oct 13, 2017

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide